Very excited to share the final version of our SLC46A2-NOD1 skin inflammation story, published today in Immunity. Publicly available at authors.elsevier.com/sd/article/S10…. Thread below present a brief overview of our findings.

Thrilled to share our recent paper published online today at Nature Cancer led by our talented postdoc Lo Chibaya and in collaboration with Lowe Lab and others at UMass Chan Medical School UMass Cancer Center Molecular, Cell and Cancer Biology and Memorial Sloan Kettering Cancer Center! rdcu.be/dbmYH nature.com/articles/s4301…

Thanks to an ALSF POST Award Alex's Lemonade Stand Foundation, we're very excited to have Christian Bernard Alarcon join us this summer to work on innate immunomodulatory nanoparticle therapies for neuroblastoma! UMass Biomedical Engineering UMass Chan Program in Innate Immunity UMass Chan Medical School

Well done Madeleine Oudin and thank you for speaking up!!

Very proud of Griffin Kane Griffin Kane and Meghan Brassil presenting their work at the 2023 Cancer Nanotechnology Gordon Research Conferences that focuses on tumor microenvironment immunomodulation! What an exciting meeting! UMass Biomedical Engineering UMass Cancer Center

As a true visionary, Michael Green's support of the unique cross-campus UMass Biomedical Engineering effort between UMass Amherst and UMass Chan Medical School left an indelible mark on me as a new PI. UMass has lost a titan. What an immense legacy he has left for us to honor.

Our “vaccine + CAR T -> antigen spreading” story is finally online🥳 —an effective approach to enhance CAR T therapy against solid tumors with antigen heterogeneity. We are recruiting motivated postdocs to continue this exciting research! Please spread the words 🥳

Our lab at #UMassAmherst is looking for a research technician to contribute to our work in #TB mouse models and pulmonary #InnateImmunity. We're collaborative, inclusive, and enthusiastic. You are too? Please apply! 👇👇👇 careers.umass.edu/amherst/en-us/…

Thanks to NIBIB Trailblazer support, we are growing our team UMass Biomedical Engineering UMass Cancer Center!! If you are interested in developing lipid-based nanoparticles as novel vaccine adjuvants for cancer, contact me! umass.edu/news/article/c…

We are excited too! Here is our preprint in collaboration with Marcus Ruscetti Lab on the rational development of combination immunotherapies using nanoparticle platforms for aggressive cancers like PDAC

We are hiring! A full-time postdoctoral position in cancer immunotherapy and immunoengineering for an Innosuisse project is immediately available in the Tang lab (tang-lab.epfl.ch) at EPFL, Switzerland. pl contact me ([email protected]). pl spread the word. Thanks!

A BIG CONGRATS to Griffin Kane (Griffin Kane), Christina Lusi, and Meghan Brassil on their review paper out ESMO IOTECH, in a special issue edited by Prof. Li Tang (Li Tang), on engineering approaches for remodeling innate immunity in the TME! UMass Biomedical Engineering UMass Cancer Center

We are looking for a Research Technologist/Lab Manager to fill a unique role with research and supervisory responsibilities. If you are interested in nanoparticle engineering, immunotherapy, and drug delivery, please apply! UMass Biomedical Engineering careers.umass.edu/amherst/en-us/…

Couldn't agree more! Welcome Haruka, very excited to have you join our teams and looking forward to working together on this idea!

A great team effort indeed, we're excited to share this paper in collaboration with the Ruscetti lab Marcus Ruscetti Lab!

We are excited for BRIDGE fund support to build on the translational aspects of this multi-targeted, multi-therapeutic LNP platform approach in collaboration with Marcus Ruscetti Lab

Our summer lab celebration has become a tradition with the Nandadasa lab TheNandadasaLab! Minus the badminton due to rain this year, but a proper party nonetheless to celebrate fellowships won, manuscripts accepted, exciting stories to come, and the true camaraderie of this group!

Delighted to share our opinion piece out today Trends in Immunology, led by Griffin Kane Griffin Kane and Meghan Brassil, with Miranda Diaz-Infante! Nanocarrier design takes center stage in pathogen-inspired technologies for cancer! UMass Biomedical Engineering UMass Cancer Center sciencedirect.com/science/articl…

Really happy to share our paper Science Translational Medicine, an indomitable team effort with Marcus Ruscetti Lab's group, on combining senescence therapies with nanoparticle delivery of STING/TLR4 agonists in pancreatic cancer. So proud of Lo and Kelly and everyone who has been a part of this team!

Innate immune activators packaged in lipid nanoparticles, and paired with two senescence-inducing chemotherapy agents, controlled tumor growth and extended survival in a mouse model of pancreatic ductal adenocarcinoma. Science Translational Medicine scim.ag/8eZ